PL4045022T3 - Kompozycja do zapobiegania taopatiom i ich leczenia - Google Patents
Kompozycja do zapobiegania taopatiom i ich leczeniaInfo
- Publication number
- PL4045022T3 PL4045022T3 PL20780933.6T PL20780933T PL4045022T3 PL 4045022 T3 PL4045022 T3 PL 4045022T3 PL 20780933 T PL20780933 T PL 20780933T PL 4045022 T3 PL4045022 T3 PL 4045022T3
- Authority
- PL
- Poland
- Prior art keywords
- preventing
- composition
- treating tauopathies
- tauopathies
- treating
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/075—Ethers or acetals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Mycology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Molecular Biology (AREA)
- Physiology (AREA)
- Zoology (AREA)
- Botany (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP19382778.9A EP3789018A1 (en) | 2019-09-09 | 2019-09-09 | Composition and methods for enhancing or promoting the secretion of ghrelin to promote a healthy metabolic aging |
| PCT/EP2020/075180 WO2021048195A2 (en) | 2019-09-09 | 2020-09-09 | Composition and methods for enhancing or promoting a healthy metabolic aging |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL4045022T3 true PL4045022T3 (pl) | 2025-11-17 |
Family
ID=67902476
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL20780933.6T PL4045022T3 (pl) | 2019-09-09 | 2020-09-09 | Kompozycja do zapobiegania taopatiom i ich leczenia |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20220313620A1 (pl) |
| EP (3) | EP3789018A1 (pl) |
| JP (2) | JP2022547641A (pl) |
| CN (2) | CN120938973A (pl) |
| CA (1) | CA3153663A1 (pl) |
| ES (1) | ES3041902T3 (pl) |
| PL (1) | PL4045022T3 (pl) |
| WO (1) | WO2021048195A2 (pl) |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5550166A (en) * | 1995-03-17 | 1996-08-27 | Ostlund; Richard E. | Pinitol and derivatives thereof for the treatment of metabolic disorders |
| US7521481B2 (en) * | 2003-02-27 | 2009-04-21 | Mclaurin Joanne | Methods of preventing, treating and diagnosing disorders of protein aggregation |
| US20060004096A1 (en) * | 2004-05-28 | 2006-01-05 | Joseph Larner | Method of Treating Endothelial Dysfunction, Oxidative Stress and Related Diseases |
| JP2008510494A (ja) * | 2004-08-25 | 2008-04-10 | マルチ・フォーミュレーションズ・リミテッド | 骨格筋における異化過程の失活及びタンパク質合成のための組成物並びに方法 |
| US8193250B2 (en) * | 2004-10-22 | 2012-06-05 | Mount Sinai School Of Medicine | Compositions and methods for treating alzheimer's disease and related disorders and promoting a healthy nervous system |
| WO2008025116A1 (en) * | 2006-08-31 | 2008-03-06 | New Nitro Formulations Ltd. | Composition and method for enhancing or promoting the activity of insulin, enhancing skeletal muscle growth, reducing skeletal muscle loss, and increasing the energy supply to skeletal muscle |
| KR100844363B1 (ko) * | 2007-09-05 | 2008-07-07 | 충남대학교산학협력단 | D-피니톨을 유효성분으로 포함하는 골 대사성 질환의 예방 또는 치료용 조성물 |
| CN101612142A (zh) * | 2008-06-25 | 2009-12-30 | 广州威尔曼新药开发中心有限公司 | 肌醇衍生物或其盐在制药中的用途 |
| ITFI20110252A1 (it) * | 2011-11-22 | 2013-05-23 | Lo Li Pharma Srl | Composizione farmaceutica comprendente myo-inositolo e d-chiro-inositolo. |
| CA2941650A1 (en) * | 2014-03-05 | 2015-09-11 | Humanetics Corporation | Predicting and reducing cognitive decline based on gsk-3 levels |
| KR101671502B1 (ko) * | 2015-07-13 | 2016-11-02 | 주식회사 디와이내츄럴 | 피니톨, d-카이로-이노시톨, 또는 이들의 유사 화합물을 유효성분으로 포함하는 여성 갱년기 증상의 개선, 예방, 또는 치료용 조성물 |
| JP6838146B2 (ja) * | 2016-10-06 | 2021-03-03 | ディーワイ ナチュラル カンパニー リミテッド | ピニトール、d−カイロ−イノシトール、又はこれらの類似化合物を有効成分として含む、女性の更年期症状の改善、予防、又は治療用の組成物 |
-
2019
- 2019-09-09 EP EP19382778.9A patent/EP3789018A1/en not_active Withdrawn
-
2020
- 2020-09-09 PL PL20780933.6T patent/PL4045022T3/pl unknown
- 2020-09-09 CN CN202511112180.7A patent/CN120938973A/zh active Pending
- 2020-09-09 CA CA3153663A patent/CA3153663A1/en active Pending
- 2020-09-09 JP JP2022541315A patent/JP2022547641A/ja active Pending
- 2020-09-09 US US17/641,734 patent/US20220313620A1/en active Pending
- 2020-09-09 WO PCT/EP2020/075180 patent/WO2021048195A2/en not_active Ceased
- 2020-09-09 ES ES20780933T patent/ES3041902T3/es active Active
- 2020-09-09 CN CN202080077416.7A patent/CN114641281A/zh active Pending
- 2020-09-09 EP EP20780933.6A patent/EP4045022B1/en active Active
- 2020-09-09 EP EP25184120.1A patent/EP4599696A3/en active Pending
-
2025
- 2025-08-14 JP JP2025135132A patent/JP2025169353A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| WO2021048195A9 (en) | 2022-04-21 |
| JP2025169353A (ja) | 2025-11-12 |
| CN120938973A (zh) | 2025-11-14 |
| JP2022547641A (ja) | 2022-11-14 |
| EP4045022A2 (en) | 2022-08-24 |
| CN114641281A (zh) | 2022-06-17 |
| CA3153663A1 (en) | 2021-03-18 |
| EP4045022B1 (en) | 2025-07-09 |
| EP4045022C0 (en) | 2025-07-09 |
| US20220313620A1 (en) | 2022-10-06 |
| EP4599696A2 (en) | 2025-08-13 |
| WO2021048195A3 (en) | 2021-04-29 |
| EP3789018A1 (en) | 2021-03-10 |
| ES3041902T3 (en) | 2025-11-17 |
| EP4599696A3 (en) | 2026-01-07 |
| WO2021048195A2 (en) | 2021-03-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11202104158SA (en) | Composition and method for treating the lungs | |
| SG11202103405TA (en) | Compounds and compositions for treating conditions associated with nlrp activity | |
| SG11202013239RA (en) | Composition and method for treating pain | |
| IL286350A (en) | Preparations and methods for the treatment of cancer | |
| IL288914A (en) | Preparations and methods for the treatment of cancer | |
| IL285886A (en) | Preparations and methods for the treatment of laminopathy | |
| ZA202104870B (en) | Methods and compositions for treating cancer | |
| IL271256A (en) | Preparations and methods for the treatment of teopathy | |
| IL288024A (en) | Methods and preparations for the prevention of type 1 diabetes | |
| IL285796A (en) | Methods and preparations for the treatment of cancer | |
| HUE073261T2 (hu) | Készítmények fehérje-aggregációs betegségek kezelésére és/vagy megelõzésére | |
| SG11202012055PA (en) | Methods and compositions for preventing or treating calciphylaxis | |
| IL280413A (en) | Bismuth-thiol preparations and wound treatment methods | |
| IL287982A (en) | Preparations and methods for the treatment of cancer | |
| IL286153A (en) | Methods and preparations for the treatment of cancer | |
| ZA202007183B (en) | Compositions and methods for treating the eye | |
| IL288440A (en) | Materials and methods for the treatment of retinopathy | |
| GB202001422D0 (en) | Compositions and methods for preventing or treating nephrolithiasis | |
| SG11202107355RA (en) | Improved method and compositions for surface treatment | |
| GB202110228D0 (en) | Compositions and methods for preventing or treating incontinence, overactive bladder, or menstrual cramping | |
| GB2596927B (en) | Composition for preventing or treating dementia and improving cognitive ability | |
| GB2579687B (en) | Composition and method | |
| PL4045022T3 (pl) | Kompozycja do zapobiegania taopatiom i ich leczenia | |
| IL285036A (en) | Methods and preparations for the treatment of cancer | |
| SG11202112052VA (en) | Compositions and methods for treating presbyopia |